Research and Development of Cancer Screening Test Kits [Saitama University, Faculty of Engineering]
Utilization of calmodulin-binding peptides that bind to midkine!
We would like to introduce the research and development of a cancer screening test kit. "Calmodulin-binding peptide (CBP)" can be applied as a peptide aptamer for detecting midkine (MK) in screening test kits. Since it does not bind to similar epitopes, which is a challenge with antibodies, it has high specificity. Additionally, it can be manufactured using chemical synthesis methods, allowing for a cost reduction to less than 1/10 of conventional methods. [Features] ■ Binding affinity of MK-CBP - Strong intermolecular interactions confirmed ■ Specificity of MK-CBP binding - mtCBP (mutant type) showed high specificity for MK *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Cancer Marker Test Kit Application Image】 ■ Detectable cancer types: Stomach cancer, colorectal cancer, and many others ■ Target molecule: Midkine (neurotrophic factor) ■ Test specimens: Blood, urine, etc. *For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs![Research and development of cancer screening test kits [Saitama University, Faculty of Engineering]](https://image.mono.ipros.com/public/catalog/image/01/68d/810129/IPROS15713623159745819653.jpeg?w=120&h=170)
Company information
Since our establishment, we have been supporting the commercialization of various companies. We have extensive experience and achievements in commercializing technologies developed at universities and launching new businesses utilizing subsidies. We will introduce researchers and technology seeds suitable for your company's products, technology development, and research. Please feel free to contact us.